

Active Ingredients:
Action mechanism and therapeutic effect of the medication:
Fosamax contains the active ingredient alendronate which belongs to a group of medicines called bisphosphonates which are localized in the areas of active bone resorption. Alendronate inhibits the process of production of new bone tissue and contributes to the formation of normal bone tissue. In therapeutic doses alendronate does not cause osteomalacia.
Medical indications: Fosamax is approved to treat the following conditions:
Fosamax contraindications, precautions and warnings:
Fosamax should not be taken in:
Fosamax should be used with caution in: aggravation of digestive tract diseases. It is not recommend to indicate Fosamax to patients with kidney dysfunction in creatinine clearance less than 33ml/min.
Fosamax side effects: As with any other drug, side effects can occur with Fosamax. However, it does not mean that everyone who takes the medicine will experience these adverse effects. In most cases the preparation is well tolerated. Fosamax may cause the following side effects:
If any side effects occur during the treatment make sure to consult your health care provider immediately. If you are unsure about anything related to Fosamax, please talk to your doctor or pharmacist.
Drug interaction:
Fosamax can potentially interact with the following groups of drugs:
It is possible that all drug interactions are not presented above. For this reason, we recommend you to talk with your health care provide about drug interactions with Fosamax which may apply to you.
Additional information for the patients:
The preparation should be taken according to your doctor's recommendations. Never take the drug for conditions which are not presented in the the drug's leaflet. Try to keep the medicine out of the reach of children.